Process Industries · Chemicals: Specialty · NSE: FISCHER · data 2026-10-09
Fischer Medical Ventures Ltd
Health check: Weak (2.9/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹30.37
Market cap
₹2,080 cr
P/E
68.1
P/B
—
ROE
8.9%
ROCE
12.8%
Debt / equity
0.28
Dividend yield
0.16%
1-year return
-68.5%
52-week high
₹121.7
52-week low
₹29.9
Operating margin
12.7%
Growth
| Revenue (last 12 months) | ₹367 cr |
| Net profit (last 12 months) | ₹30 cr |
| Sales growth, 3 years (yearly) | 1097.9% |
| Profit growth, 3 years (yearly) | — |
Chart patterns
- Double top — breakdown (key level ₹34.06)
Similar companies
JG Chemicals Limited (JGCHEM) · India Glycols Limited (INDIAGLYCO) · Rossari Biotech Ltd (ROSSARI) · S H Kelkar and Company Ltd (SHK) · IG Petrochemicals Ltd. (IGPL)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open FISCHER in NSE Scanner →